Real-world (RW) risk of recurrence among patients (pts) diagnosed with stage II-III HR+/HER2-early breast cancer (EBC) treated with endocrine therapy (ET) in the US Meeting Abstract

  

Authors:	Razavi, P.; Ahmed, M.; Roush, A.; Parikh, R.; Hitchens, A.; Shen, S.; Safonov, A.; Jhaveri, K. L.; Robson, M. E.; Peacock, N. W.; Ma, Y.; Santarsiero, E. C.; Ganapathy, V.; Shah, R. M.; Amefule, A. Q.; Lteif, A.; Blakely, L. J.
Abstract Title:	Real-world (RW) risk of recurrence among patients (pts) diagnosed with stage II-III HR+/HER2-early breast cancer (EBC) treated with endocrine therapy (ET) in the US
Meeting Title:	2024 ASCO Annual Meeting
Journal Title:	Journal of Clinical Oncology
Volume:	42
Issue:	16 Suppl.
Meeting Dates:	2024 May 31-Jun 4
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2024-06-01
Language:	English
ACCESSION:	WOS:001275557403004
PROVIDER:	wos
DOI:	10.1200/JCO.2024.42.16_suppl.e12533
Notes:	Meeting Abstract: e12533 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/218783